MSD
The 2027 Future Talent Program offers two six-month computational co-op roles in Translational Genome Analytics, providing students with hands-on experience in drug-discovery research. Participants will apply computational methods to analyze genomic and transcriptomic datasets to support target and biomarker discovery in oncology and immunology. The program aims to develop student skills while evaluating potential long-term fit within the team.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Scientist, Oncology Bioinformatics
Moderna
Senior Scientist - Computational Discovery & Translational Analytics
lifelancer
Translational Scientist (Senior)
Bioptimus
Postdoctoral Fellow in Computational Cancer Biology
Dana-Farber Cancer Institute
Computational Biology Scientist
GondolaBio Service Co, Inc.
Principal Scientist, Bioinformatics
Nkarta, Inc.